Skip to content

Study on the effect of low molecular weight heparin on pregnancy outcome after embryo transplantation in women with poor uterine artery perfusion

Study on the effect of low molecular weight heparin on pregnancy outcome after embryo transplantation in women with poor uterine artery perfusion

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041133
Enrollment
Unknown
Registered
2020-12-19
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility (Recurrent implantation failure)

Interventions

Control group:Standard luteal support protocol
LMWH group:Standard luteal support protocol and low molecular weight heparin

Sponsors

Shanghai Jiaotong University School of Medicine, Renji Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 39 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 25-39 years old; 2. Patients with body mass index (BMI) in the normal range of 18.5-23.9 kg / m2; 3. Patients with ET failure more than 2 times in the past and at least one high-quality embryo at each time of transplantation; 4. In the embryo transfer cycle, patients whose endometrium reached the transplantation standard had high resistance to uterine artery blood flow; 5. Patients with normal coagulation related indexes such as international normalized ratio (INR), D-dimer and coagulation factor X.

Exclusion criteria

Exclusion criteria: 1. The recipients who cancelled the transfer due to failure of embryo resuscitation or other factors; 2. Subjects who did not complete the frozen embryo transfer cycle for some reason; 3. Subjects confirmed or suspected to be allergic to the test drug; 4. Patients with active bleeding and cardiovascular disease; 5. Subjects judged by the researcher not suitable for the study, such as communication disorder (language or intelligence).

Design outcomes

Primary

MeasureTime frame
clinical pregnancy rate;embryo implantation rate;

Secondary

MeasureTime frame
Early pregnancy loss rate;

Countries

China

Contacts

Public ContactGao Minzhi

Renji Hospital Affiliated to Medical College of Shanghai Jiaotong University

gaominzhi@renji.com+86 13818864953

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026